Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Total 13F shares
-
45,107,658
-
Share change
-
-1,747,743
-
Total reported value
-
$5,577,956,857
-
Put/Call ratio
-
117%
-
Price per share
-
$123.61
-
Number of holders
-
361
-
Value change
-
-$195,603,627
-
Number of buys
-
189
-
Number of sells
-
159
Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2020
As of 30 Jun 2020,
REPLIGEN CORP - COMMON STOCK (RGEN) was held by
361 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,107,658 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., STATE STREET CORP, Conestoga Capital Advisors, LLC, 12 West Capital Management LP, and Select Equity Group, L.P..
This page lists
363
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.